Expression of tropomyosin isoforms in benign and malignant human breast lesions
1996

Tropomyosin Isoforms in Breast Cancer

Sample size: 25 publication Evidence: moderate

Author Information

Author(s): B Franzen, S Linder, K Uryu, AA Alai, T Hirano, H Kato, G Auer

Primary Institution: Karolinska Institute and Hospital

Hypothesis

The expression of high molecular weight tropomyosin isoforms is down-regulated in breast carcinomas compared to non-cancerous breast lesions.

Conclusion

High molecular weight tropomyosin isoforms are expressed at lower levels in primary breast carcinomas, with metastatic tumors showing relatively higher levels of tropomyosin 1.

Supporting Evidence

  • The expression of high molecular weight tropomyosins was found to be 4-5 fold higher in non-cancerous lesions compared to carcinomas.
  • Tm 1 levels were significantly higher in node-positive compared to node-negative breast carcinomas.
  • Down-regulation of tropomyosin expression was observed in transformed fibroblasts and breast carcinoma cell lines.

Takeaway

This study found that certain proteins called tropomyosins are less common in breast cancer than in healthy breast tissue, and that cancerous tissues with spread to lymph nodes have more of one type of tropomyosin.

Methodology

The study analyzed tropomyosin isoform expression in non-cancerous breast lesions and primary human breast carcinomas using two-dimensional gel electrophoresis.

Limitations

The study may not fully represent all types of breast cancer due to the limited sample size and specific types of lesions examined.

Participant Demographics

The study included 20 malignant breast tumors (10 node-negative and 10 node-positive) and 5 non-cancerous breast lesions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication